ENvue Medical, Inc. Cash Flow Statement
FEED|11 years of annual SEC 10-K data (FY2015-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 11 fiscal years. All figures from audited SEC 10-K filings.
ENvue Medical, Inc. used $3M in operating cash flow and negative free cash flow of $3M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -0.19 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$3.7M | -$3.7M | -$5.4M | -$14.3M | -$4.3M | -$5.8M | -$4.2M | -$5.0M | -$2.8M | -$2.9M | -$2.6M |
| Depreciation & Amortization | $1.0K | $1.0K | $1.0K | $2.0K | $2.0K | $4.0K | $6.0K | $5.0K | $7.0K | $9.0K | $9.0K |
| Operating Cash Flow | -$2.5M | -$3.6M | -$7.0M | -$4.4M | -$3.4M | -$3.9M | -$3.5M | -$2.2M | -$1.5M | -$1.5M | -$900.0K |
| Capital Expenditures | $3.0K | $1.0K | $3.0K | $3.0K | $2.0K | $2.0K | $8.0K | $8.0K | $8.0K | $1.0K | $4.0K |
| Free Cash Flow | -$2.5M | -$3.6M | -$7.0M | -$4.4M | -$3.4M | -$3.9M | -$3.6M | -$2.2M | -$1.5M | -$1.5M | -$904.0K |
| FCF Margin | -98.5% | -157.8% | -935.9% | -257.8% | -544.6% | -731.3% | -1118.9% | -916.3% | -672.9% | -1007.5% | -445.3% |